EUVIMEDEUVIMED entdecken
Crossref

GLP-1 Medication Adoption and Household Demand for Ultra-Processed Foods

Awad, Koroles, Ehmke, Mariah, McCluskey, Jill J., Okrent, Abigail

AgEcon Search (University of Minnesota, USA) · 01.01.2025

DOI: 10.22004/ag.econ.379044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AgEcon Search (University of Minnesota, USA), erschienen am 01.01.2025. Verfasst von Awad und 7 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper investigates how the introduction of Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications affects household food-at-home purchasing behavior. Using household scanner data, we link detailed food purchases with household prescription purchases to identify the timing of GLP-1 adoption on food purchasing behaviors. To measure shifts in food processing levels, we classify more than five million products into four NOVA categories (i.e., minimally processed, culinary ingredients, processed and ultra-processed) using a hybrid system that combines best-practice hand classification with a high-accuracy machine-learning algorithm based on product descriptions and ingredient lists. We estimate causal effects of GLP-1 on food purchasing behaviors using the staggered-adoption difference-in-differences approach, comparing GLP-1 adopters with households initiating non-GLP-1 diabetes medications. We find that the introduction of GLP-1 leads to a statistically significant reduction of approximately $56 per month in total food spending and induces a systematic reallocation of the household food budget away from ultra-processed foods and toward minimally processed foods. Although dollar-value changes in ultra-processed purchases exhibit heterogeneity, the decline in the budget share of ultra-prcocessed foods and the increase in minimally processed foods are robust across specifications. These findings suggest that GLP-1 medications generate meaningful improvements in dietary composition, with implications for public health policy and for food manufacturers likely to be affected by shifts in consumer demand as GLP-1 adoption increases.

Schlagwörter

GLP-1 receptor agonistsultra-processed foodsNOVA classificationfood purchasinghousehold food expenditureminimally processed foodsantidiabetic drugsdiet compositionfood processing level

Zitieren

APA

Awad, Koroles, Ehmke, Mariah, McCluskey, J., J., Okrent, & Abigail (2025). GLP-1 Medication Adoption and Household Demand for Ultra-Processed Foods. AgEcon Search (University of Minnesota, USA). https://doi.org/10.22004/ag.econ.379044

Vancouver

Awad, Koroles, Ehmke, Mariah, McCluskey, J. J, et al. GLP-1 Medication Adoption and Household Demand for Ultra-Processed Foods. AgEcon Search (University of Minnesota, USA). 2025. doi:10.22004/ag.econ.379044

BibTeX
@article{Awad2025,
  author = {Awad and Koroles and Ehmke and Mariah and McCluskey and J., Jill and Okrent and Abigail},
  title = {GLP-1 Medication Adoption and Household Demand for Ultra-Processed Foods},
  journal = {AgEcon Search (University of Minnesota, USA)},
  year = {2025},
  doi = {10.22004/ag.econ.379044}
}
Kostenlos starten →